Ueda Shinobu | Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
スポンサーリンク
概要
- UEDA Shinobuの詳細を見る
- 同名の論文著者
- Experimental Pathology And Chemotherapy Division National Cancer Center Research Instituteの論文著者
関連著者
-
Tsuda Hiroyuki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Ueda Shinobu
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya Ci
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Asamoto Makoto
国立がんセンター
-
Asamoto Makoto
住友製薬大阪研究所
-
Park Cheol
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Mutai Mamoru
First Department Of Pathology Nagoya City University Medical School
-
Tanaka Harunari
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Tsuda Hiroyuki
First Department Of Pathology Nagoya City University Medical School
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Tsuda H
Keio Univ. Yokohama‐shi Jpn
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University
-
Nomoto H
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
FUKAMACHI Katsumi
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
NAITO Akihiro
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
SUZUKI Akane
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
UEDA Shinobu
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
NOMOTO Hiroshi
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
TORIYAMA BABA
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
ASAMOTO Makoto
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Kim Chuel
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Toriyama‐baba H
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Toriyama Baba
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Fujita Ken-ichi
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Tanaka H
Department Of Cancer Control And Statistics Osaka Medical Center For Cancer And Cardiovascular Disea
-
Tsuda Hiroyuki
Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Han Beom
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Suzuki Akane
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Naito Akihiro
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Asamoto Makoto
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Tsuda H
Department Of Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Nomoto Hiroshi
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Tsuda Hiroyuki
Dep. Of Molecular Toxicology Nagoya City Univ.
-
Takasuka Nobuo
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
HAMAGUCHI Tetsuya
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
著作論文
- Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats
- Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7, 12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate